Gastric residual volume evaluation with ultrasonography after intravenous ondansetron and metoclopramide and neostigmine :A Double Blind Randomized clinical Trial

Phase 3

Recruiting

• Conditions: Gastric volume after gavage.; Gastro-esophageal reflux disease without esophagitis; K21.9

• Registration Number: IRCT20190215042716N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients 18 to 80 years
Patients hospitalized in ICU
Patients with nasogastric tube or percutaneous gastrostomy tube

Exclusion Criteria

Do not place the nasal gastric tube in the stomach
Prisoners
Ileus
Long-term fasting planning
The remaining volume of the stomach is not examined by nurses for any reason

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Size of gastric residual volume on ultrasound. Timepoint: Patients were studied after 5 half-lives of drug from the third day and 4 hours after morning gavage for the next 4 days. Method of measurement: Sonography device.